Grakof Expectorant (110 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Gracure Pharmaceuticals Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ammonium Chloride, Chlorpheniramine Maleate,Sodium Citrate. This drug comes in the form of Expectorant. The general packing available for this medicine consists of 110 ml and is priced at Rs 28 (arround $0.392 US Dollar)
The main active ingredients or salts in Grakof Expectorant (110 ml) are :
Ammonium Chloride-125 mg
Chlorpheniramine Maleate-2.5 mg
Sodium Citrate-55 mg
Ammonium Chloride Indication (Prescribed for or used as):
For more details on Ammonium Chloride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ammonium Chloride..
Chlorpheniramine Maleate Indication (Prescribed for or used as): Allergic conditions. Adjunct in the emergency treatment of anaphylactic shock.
For more details on Chlorpheniramine Maleate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Chlorpheniramine Maleate..
Sodium Citrate Indication (Prescribed for or used as):
For more details on Sodium Citrate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Sodium Citrate..
Grakof Expectorant (110 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 10 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Grakof Expectorant (110 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ammonium Chloride-125 mg Chlorpheniramine Maleate-2.5 mg Sodium Citrate-55 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.